Massive south african trial tests 'Treat All' strategy to stop HIV
NCT ID NCT01509508
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This large study in South Africa tested whether offering HIV treatment to everyone right after diagnosis, instead of waiting until their immune system weakened, could reduce new HIV infections across entire communities. Over 28,000 people from 22 communities took part. The idea is that treating people early lowers the amount of virus in their body, making it much less likely to pass HIV to others.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Atripla (tenofovir/emtricitabine/efavirenz)
What this could lead to
If successful, this strategy could show that immediate HIV treatment for everyone diagnosed dramatically lowers new infections in a community, pointing toward a way to control the epidemic.
What could go wrong
This is a large trial, but results depend on real-world uptake and adherence. The strategy may not work as well in other settings or populations, and side effects from lifelong medication are a concern.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hlabisa Hospital
Hlabisa, KwaZulu-Natal, 3937, South Africa